ArticlePlanta2026
Transcription factor MYB102 regulates plant growth and tolerance to multiple abiotic stresses in Arabidopsis thaliana.
Article in Planta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
MAIN
conclusionAtMYB102 negatively regulates the growth of Arabidopsis thaliana while positively modulating its tolerance to drought, salt, and freezing stresses. Abiotic stress, including from drought, salt, and extreme temperatures, poses a significant challenge to crop growth. Myeloblastosis (MYB) transcription factors have been shown to significantly impact plant growth, development, and physiological metabolism. However, the role of MYB102 in the growth and abiotic stress response of Arabidopsis thaliana has not been thoroughly investigated. This study demonstrated that the loss-of-function mutant myb102 exhibited accelerated seed germination, a larger cotyledon area, and an earlier flowering time compared to the Arabidopsis wild-type Columbia-0 (Col-0), while the overexpression of AtMYB102 (MYB102-OE) led to delayed seed germination, a reduced cotyledon area, and later flowering. RNA sequencing (RNA-seq) of myb102 and MYB102-OE indicated that AtMYB102 was associated with growth, development, and oxidative stress response. The expression of AtMYB102 was upregulated by treatment with the stress hormone abscisic acid (ABA). Further analysis showed that under drought, salt, and freezing stresses, the myb102 mutant displayed decreased survival rates and increased levels of reactive oxygen species (ROS) compared to Col-0. In contrast, MYB102-OE plants showed higher survival rates and lower ROS levels under the same stress conditions. These results point toward a role for AtMYB102 in regulating plant growth, development, and tolerance to multiple abiotic stresses.
Indexed as
Identifiers
42437400What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.